NVCR
Closed
Novocure Ltd
17.88
+0.08 (+0.45%)
Last Update: 01 Jul 2025 23:15:00
Yesterday: 17.8
Day's Range: 17.525 - 18.605
Send
sign up or login to leave a comment!
When Written:
63.01
Novocure Ltd is a global oncology company that develops and commercializes innovative therapies for cancer patients. The company's proprietary therapy, Tumor Treating Fields (TTFields), is a non-invasive treatment that uses electric fields to disrupt cancer cell division and inhibit tumor growth. The therapy is approved for the treatment of glioblastoma, a type of brain cancer, and mesothelioma, a type of cancer that affects the lining of the lungs and abdomen.
Novocure was founded in 2000 and is headquartered in Jersey, Channel Islands. The company has operations in the United States, Europe, and Asia and employs over 1,000 people worldwide. Novocure's mission is to extend survival and improve quality of life for cancer patients by developing and commercializing innovative therapies that target the underlying biology of cancer.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Novocure was founded in 2000 and is headquartered in Jersey, Channel Islands. The company has operations in the United States, Europe, and Asia and employs over 1,000 people worldwide. Novocure's mission is to extend survival and improve quality of life for cancer patients by developing and commercializing innovative therapies that target the underlying biology of cancer.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








